KURA

6.9405.58%
TD

Thomas Doyle

Senior Vice President of Finance & Accounting

Mr. Thomas Doyle, also known as Tom, is Senior Vice President of Finance and Accounting of Kura Oncology, Inc since February 7, 2022. He was Vice President of Finance at Kura Oncology, Inc. since June 2021 until February 7, 2022. He joined Kura in June 2021 with experience in the biopharma industry, leading finance teams from early stage through commercialization. Most recently, he was Vice President of Finance at Zogenix, supporting the clinical trials and launch of multiple therapies. Prior to Zogenix, Mr. Doyle was the Controller for Peregrine Pharmaceuticals, an oncology development and biomanufacturing company. He has also served as the Director of Revenue and Cost Accounting at ISTA Pharmaceuticals and the Director of Internal Audit and R&D Finance at Valeant Pharmaceuticals. Mr. Doyle is a certified public accountant and received his MBA from California State University San Marcos and his Bachelor of Science in finance from San Diego State University.

Positions